210 related articles for article (PubMed ID: 16636230)
1. Antiplatelets, ACE inhibitors, and statins combination reduces stroke severity and tissue at risk.
Kumar S; Savitz S; Schlaug G; Caplan L; Selim M
Neurology; 2006 Apr; 66(8):1153-8; discussion 1135. PubMed ID: 16636230
[TBL] [Abstract][Full Text] [Related]
2. Prior antiplatelet use and infarct volume in ischemic stroke.
Ovbiagele B; Buck BH; Liebeskind DS; Starkman S; Bang OY; Ali LK; Villablanca JP; Salamon N; Yun SW; Pineda S; Saver JL
J Neurol Sci; 2008 Jan; 264(1-2):140-4. PubMed ID: 17854835
[TBL] [Abstract][Full Text] [Related]
3. Effect of prestroke use of angiotensin-converting enzyme inhibitors alone versus combination with antiplatelets and statin on ischemic stroke outcome.
Hassan Y; Al-Jabi SW; Aziz NA; Looi I; Zyoud SH
Clin Neuropharmacol; 2011; 34(6):234-40. PubMed ID: 21996648
[TBL] [Abstract][Full Text] [Related]
4. Effect of pre-stroke use of ACE inhibitors on ischemic stroke severity.
Selim M; Savitz S; Linfante I; Caplan L; Schlaug G
BMC Neurol; 2005 Jun; 5(1):10. PubMed ID: 15949043
[TBL] [Abstract][Full Text] [Related]
5. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators.
Warach S; Pettigrew LC; Dashe JF; Pullicino P; Lefkowitz DM; Sabounjian L; Harnett K; Schwiderski U; Gammans R
Ann Neurol; 2000 Nov; 48(5):713-22. PubMed ID: 11079534
[TBL] [Abstract][Full Text] [Related]
6. Impact of the additive effect of angiotensin-converting enzyme inhibitors and /or statins with antiplatelet medication on mortality after acute ischaemic stroke.
Hassan Y; Al-Jabi SW; Aziz NA; Looi I; Zyoud SH
Basic Clin Pharmacol Toxicol; 2012 Apr; 110(4):370-7. PubMed ID: 22023326
[TBL] [Abstract][Full Text] [Related]
7. Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemia.
Schellinger PD; Fiebach JB; Jansen O; Ringleb PA; Mohr A; Steiner T; Heiland S; Schwab S; Pohlers O; Ryssel H; Orakcioglu B; Sartor K; Hacke W
Ann Neurol; 2001 Apr; 49(4):460-9. PubMed ID: 11310623
[TBL] [Abstract][Full Text] [Related]
8. Is prestroke use of angiotensin-converting enzyme inhibitors associated with better outcome?
Chitravas N; Dewey HM; Nicol MB; Harding DL; Pearce DC; Thrift AG
Neurology; 2007 May; 68(20):1687-93. PubMed ID: 17502550
[TBL] [Abstract][Full Text] [Related]
9. Etiology of perfusion-diffusion magnetic resonance imaging mismatch patterns.
Restrepo L; Jacobs MA; Barker PB; Beauchamp NJ; Skolasky RL; Keswani SC; Wityk RJ
J Neuroimaging; 2005 Jul; 15(3):254-60. PubMed ID: 15951408
[TBL] [Abstract][Full Text] [Related]
10. Pre-stroke use of antihypertensives, antiplatelets, or statins and early ischemic stroke outcomes.
Yu AY; Keezer MR; Zhu B; Wolfson C; Côté R
Cerebrovasc Dis; 2009; 27(4):398-402. PubMed ID: 19276623
[TBL] [Abstract][Full Text] [Related]
11. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
12. Patients with diffusion-perfusion mismatch on magnetic resonance imaging 48 hours or more after stroke symptom onset: clinical and imaging features.
Perez A; Restrepo L; Kleinman JT; Barker P; Beauchamp N; Wityk RJ
J Neuroimaging; 2006 Oct; 16(4):329-33. PubMed ID: 17032382
[TBL] [Abstract][Full Text] [Related]
13. [Intravenous administration of a tissue plasminogen activator beyond 3 hours of the onset of acute ischemic stroke--MRI-based decision making].
Kakuda W; Abo M
Brain Nerve; 2008 Oct; 60(10):1173-80. PubMed ID: 18975605
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin 2 type 2 receptor activity and ischemic stroke severity.
Ovbiagele B; Kidwell CS; Starkman S; Selco SL; Rajajee V; Razinia T; Saver JL
Neurology; 2005 Sep; 65(6):851-4. PubMed ID: 16186522
[TBL] [Abstract][Full Text] [Related]
15. Ischemic diffusion lesion reversal is uncommon and rarely alters perfusion-diffusion mismatch.
Chemmanam T; Campbell BC; Christensen S; Nagakane Y; Desmond PM; Bladin CF; Parsons MW; Levi CR; Barber PA; Donnan GA; Davis SM;
Neurology; 2010 Sep; 75(12):1040-7. PubMed ID: 20720188
[TBL] [Abstract][Full Text] [Related]
16. The effect of statin pretreatment on infarct volume in ischemic stroke.
Nicholas JS; Swearingen CJ; Thomas JC; Rumboldt Z; Tumminello P; Patel SJ
Neuroepidemiology; 2008; 31(1):48-56. PubMed ID: 18560243
[TBL] [Abstract][Full Text] [Related]
17. MR diffusion-weighted imaging and outcome prediction after ischemic stroke.
Hand PJ; Wardlaw JM; Rivers CS; Armitage PA; Bastin ME; Lindley RI; Dennis MS
Neurology; 2006 Apr; 66(8):1159-63. PubMed ID: 16525124
[TBL] [Abstract][Full Text] [Related]
18. Early ischemic lesion recurrence within a week after acute ischemic stroke.
Kang DW; Latour LL; Chalela JA; Dambrosia J; Warach S
Ann Neurol; 2003 Jul; 54(1):66-74. PubMed ID: 12838521
[TBL] [Abstract][Full Text] [Related]
19. 3-Tesla versus 1.5-Tesla magnetic resonance diffusion and perfusion imaging in hyperacute ischemic stroke.
Kosior RK; Wright CJ; Kosior JC; Kenney C; Scott JN; Frayne R; Hill MD
Cerebrovasc Dis; 2007; 24(4):361-8. PubMed ID: 17690549
[TBL] [Abstract][Full Text] [Related]
20. The use of PWI and DWI measures in the design of "proof-of-concept" stroke trials.
Barber PA; Parsons MW; Desmond PM; Bennett DA; Donnan GA; Tress BM; Davis SM
J Neuroimaging; 2004 Apr; 14(2):123-32. PubMed ID: 15095557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
